Cite
HARVARD Citation
Ang, L. et al. (2017). Elevated Baseline Serum Fibrinogen: Effect on 2‐Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention. Journal of the American Heart Association. 6 (11), p. n/a. [Online].